These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 39278156)
1. A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs. Bailey K; Schecter A; Eger WH; Justin Valasek CCJ; Strathdee SA; Knox A; Harvey-Vera A; Vera CF; Goldenberg SM; Bazzi AR; Davidson PJ Int J Drug Policy; 2024 Nov; 133():104577. PubMed ID: 39278156 [TBL] [Abstract][Full Text] [Related]
2. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings. Kolla G; Strike C Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088 [TBL] [Abstract][Full Text] [Related]
3. "I'm not going to lay back and watch somebody die": a qualitative study of how people who use drugs' naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention. Kesich Z; Ibragimov U; Komro K; Lane K; Livingston M; Young A; Cooper HLF Harm Reduct J; 2023 Nov; 20(1):166. PubMed ID: 37946233 [TBL] [Abstract][Full Text] [Related]
4. Overdose Education and Naloxone Distribution in the San Francisco County Jail. Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075 [TBL] [Abstract][Full Text] [Related]
5. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643 [TBL] [Abstract][Full Text] [Related]
6. Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study. Knudsen HK; Walker DM; Mack N; Kinnard EN; Huerta TR; Glasgow L; Gilbert L; Garner BR; Dasgupta A; Chandler R; Walsh SL; Tin Y; Tan S; Sprunger J; Sprague-Martinez L; Salsberry P; Saucier M; Rudorf M; Rodriguez S; Oser CB; Oga E; Nakayima J; Linas BS; Lefebvre RC; Kosakowski S; Katz RE; Hunt T; Holman A; Holloway J; Goddard-Eckrich D; Fareed N; Christopher M; Aldrich A; Adams JW; Drainoni ML Prev Med; 2024 Aug; 185():108034. PubMed ID: 38857770 [TBL] [Abstract][Full Text] [Related]
7. Social mixing and correlates of injection frequency among opioid use partnerships. Rowe C; Santos GM; Raymond HF; Coffin PO Int J Drug Policy; 2017 Mar; 41():80-88. PubMed ID: 28113118 [TBL] [Abstract][Full Text] [Related]
8. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention. Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509 [TBL] [Abstract][Full Text] [Related]
9. Overdose responses among rural people who use drugs: A multi-regional qualitative study. Baker R; Fredericksen RJ; Rudolph AE; Stopka TJ; Walters SM; Fadanelli M; Bolinski RS; Sibley AL; Stack E; Crane HM; Korthuis PT; Seal DW Harm Reduct J; 2024 May; 21(1):107. PubMed ID: 38822387 [TBL] [Abstract][Full Text] [Related]
10. Community pharmacists' attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey. O'Brien C; Klipp S; Jawa R; Wilson JD Harm Reduct J; 2024 Jul; 21(1):137. PubMed ID: 39030563 [TBL] [Abstract][Full Text] [Related]
11. Trends in overdose experiences and prevention behaviors among people who use opioids in Baltimore, MD, 2017-2019. Dayton L; Mazhnaya A; Schneider KE; Kong X; Winiker A; Davey-Rothwell M; Tobin KE; Latkin CA Drug Alcohol Depend; 2021 Apr; 221():108650. PubMed ID: 33684772 [TBL] [Abstract][Full Text] [Related]
12. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania. Pizzicato LN; Johnson CC; Viner KM Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397 [No Abstract] [Full Text] [Related]
13. Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade. Tobin K; Clyde C; Davey-Rothwell M; Latkin C Int J Drug Policy; 2018 Sep; 59():94-97. PubMed ID: 30075401 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs. Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291 [TBL] [Abstract][Full Text] [Related]
15. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300 [TBL] [Abstract][Full Text] [Related]
16. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174 [TBL] [Abstract][Full Text] [Related]
17. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. Doe-Simkins M; Quinn E; Xuan Z; Sorensen-Alawad A; Hackman H; Ozonoff A; Walley AY BMC Public Health; 2014 Apr; 14():297. PubMed ID: 24684801 [TBL] [Abstract][Full Text] [Related]
18. Addressing Fear of Negative Consequences of Overdose Response: A Qualitative Study of the Perceptions of Service Industry Workers Who Encounter an Opioid Overdose in an Urban Commercial District in Atlanta, Georgia. Febres-Cordero S; Thompson LM; Chalfant OS; Sherman ADF; Winiker AK; Kelly UA; Smith KM Workplace Health Saf; 2024 Jun; 72(6):244-252. PubMed ID: 38243156 [TBL] [Abstract][Full Text] [Related]
19. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015. Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193 [TBL] [Abstract][Full Text] [Related]
20. Stigma and drug use settings as correlates of self-reported, non-fatal overdose among people who use drugs in Baltimore, Maryland. Latkin CA; Gicquelais RE; Clyde C; Dayton L; Davey-Rothwell M; German D; Falade-Nwulia S; Saleem H; Fingerhood M; Tobin K Int J Drug Policy; 2019 Jun; 68():86-92. PubMed ID: 31026734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]